Stephen Michael Kelsey - Net Worth and Insider Trading

Stephen Michael Kelsey Net Worth

The estimated net worth of Stephen Michael Kelsey is at least $17 Million dollars as of 2024-11-05. Stephen Michael Kelsey is the See Remarks of Revolution Medicines Inc and owns about 264,408 shares of Revolution Medicines Inc (RVMD) stock worth over $15 Million. Stephen Michael Kelsey is also the EVP, R&D Head, CMO of Geron Corp and owns about 473,122 shares of Geron Corp (GERN) stock worth over $2 Million. Details can be seen in Stephen Michael Kelsey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen Michael Kelsey has not made any transactions after 2024-10-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Stephen Michael Kelsey

Stephen Michael Kelsey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen Michael Kelsey owns 4 companies in total, including Revolution Medicines Inc (RVMD) , Medivation Inc (MDVN) , and Geron Corp (GERN) among others .

Click here to see the complete history of Stephen Michael Kelsey’s form 4 insider trades.

Insider Ownership Summary of Stephen Michael Kelsey

Ticker	Comapny	Transaction Date	Type of Owner
RVMD	Revolution Medicines Inc	2024-10-14	See Remarks
MDVN	Medivation Inc	2014-02-18	SVP of New Projects
GERN	Geron Corp	2012-05-30	EVP & CMO & Oncology
		2020-11-18	director

Stephen Michael Kelsey Latest Holdings Summary

Stephen Michael Kelsey currently owns a total of 2 stocks. Among these stocks, Stephen Michael Kelsey owns 264,408 shares of Revolution Medicines Inc (RVMD) as of October 14, 2024, with a value of $15 Million and a weighting of 88.2%. Stephen Michael Kelsey also owns 473,122 shares of Geron Corp (GERN) as of May 30, 2012, with a value of $2 Million and a weighting of 11.8%.

Latest Holdings of Stephen Michael Kelsey

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
RVMD	Revolution Medicines Inc	2024-10-14	264,408	56.59	14,962,849
GERN	Geron Corp	2012-05-30	473,122	4.23	2,001,306

Holding Weightings of Stephen Michael Kelsey

Stephen Michael Kelsey Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen Michael Kelsey has made a total of 30 transactions in Revolution Medicines Inc (RVMD) over the past 5 years, including 0 buys and 30 sells. The most-recent trade in Revolution Medicines Inc is the sale of 16,666 shares on October 14, 2024, which brought Stephen Michael Kelsey around $824,800.

According to the SEC Form 4 filings, Stephen Michael Kelsey has made a total of 0 transactions in Geron Corp (GERN) over the past 5 years. The most-recent trade in Geron Corp is the sale of 9,300 shares on May 30, 2012, which brought Stephen Michael Kelsey around $12,741.

Insider Trading History of Stephen Michael Kelsey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen Michael Kelsey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephen Michael Kelsey Ownership Network

Ownership Network List of Stephen Michael Kelsey

No Data

Ownership Network Relation of Stephen Michael Kelsey

Stephen Michael Kelsey Owned Company Details

What does Revolution Medicines Inc do?

Who are the key executives at Revolution Medicines Inc?

Stephen Michael Kelsey is the See Remarks of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include General Counsel Jeff Cislini , See Remarks Margaret A Horn , and Chief Financial Officer Jack Anders .

Revolution Medicines Inc (RVMD) Insider Trades Summary

Over the past 18 months, Stephen Michael Kelsey made 15 insider transaction in Revolution Medicines Inc (RVMD) with a net sale of 186,391. Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 28,044 shares made by Jeff Cislini , a net sale of 195,672 shares made by Mark A Goldsmith , and a net sale of 147,940 shares made by Margaret A Horn .

In summary, during the past 3 months, insiders sold 190,609 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 190,609 shares. During the past 18 months, 642,995 shares of Revolution Medicines Inc (RVMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 642,995 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Medicines Inc Insider Transactions

No Available Data

What does Medivation Inc do?

Who are the key executives at Medivation Inc?

Stephen Michael Kelsey is the SVP of New Projects of Medivation Inc. Other key executives at Medivation Inc include Chief Operating Officer Marion Mccourt , VP & Finance and Accounting Tseli Lily Yang , and Interim Chief Medical Officer Mohammad Hirmand .

Medivation Inc (MDVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Medivation Inc (MDVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Medivation Inc (MDVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Medivation Inc (MDVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Medivation Inc Insider Transactions

No Available Data

What does Geron Corp do?

Who are the key executives at Geron Corp?

Stephen Michael Kelsey is the EVP & CMO & Oncology of Geron Corp. Other key executives at Geron Corp include EVP & Technical Operations Andrew J Grethlein , EVP & Corp Strategy & CCO Anil Kapur , and EVP & Chief Medical Officer Faye Feller .

Geron Corp (GERN) Insider Trades Summary

Over the past 18 months, Stephen Michael Kelsey made no insider transaction in Geron Corp (GERN). Other recent insider transactions involving Geron Corp (GERN) include a net sale of 674,348 shares made by Andrew J Grethlein , a net sale of 600,000 shares made by John A Scarlett , and a net sale of 421,875 shares made by Anil Kapur .

In summary, during the past 3 months, insiders sold 0 shares of Geron Corp (GERN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,019,123 shares of Geron Corp (GERN) were sold and 13,186 shares were bought by its insiders, resulting in a net sale of 2,005,937 shares.

Geron Corp (GERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Geron Corp Insider Transactions

No Available Data

What does Jiya Acquisition Corp do?

Who are the key executives at Jiya Acquisition Corp?

Stephen Michael Kelsey is the director of Jiya Acquisition Corp. Other key executives at Jiya Acquisition Corp include 10 percent owner Glazer Capital, Llc , 10 percent owner Paul J Glazer , and director & 10 percent owner Srinivas Akkaraju .

Jiya Acquisition Corp (JYAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Jiya Acquisition Corp (JYAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiya Acquisition Corp (JYAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jiya Acquisition Corp (JYAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jiya Acquisition Corp Insider Transactions

No Available Data

Stephen Michael Kelsey Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen Michael Kelsey. You might contact Stephen Michael Kelsey via mailing address: C/o Geron Corporation, 230 Constitution Drive, Menlo Park Ca 94025.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.